Meet Our Industry Supporters

Elevate Healthcare delivers simulation training solutions to hospitals, physicians, nurses, students, emergency responders and the military in 80 countries around the world.  With a mission to improve patient safety and outcomes, Elevate Healthcare develops each product in partnership with clinicians and clinical educators whose aim is to ensure physiological accuracy and educational relevance.  Today, Elevate Healthcare offers turnkey solutions and services as well as the broadest spectrum of medical simulation products on the market.

At Edwards Lifesciences, we strive to provide the valuable information you need to hemodynamically optimize your moderate to high-risk surgery patients. From the very first Swan-Ganz catheter to the latest ClearSight noninvasive cuff, FloTrac sensor, and EV1000 Clinical Platform, our goal remains the same: to give you the clarity you need to maintain your moderate and high-risk surgery patients in the optimal volume range. Visit Edwards.com/ESR for valuable resources for you and your surgical team.

Heron’s mission is to improve patient’s lives by developing best-in-class medicines that address major unmet medical needs. We are developing novel, patient-focused solutions that apply our innovative science and technologies to proven pharmacological agents. Our portfolio includes SUSTOL® (granisetron) and CINVANTITM (aprepitant), as well as one product in development; HTX-011, a novel fixed-dose combination of the local anesthetic bupivacaine with the nonsteroidal anti-inflammatory drug (NSAID) meloxicam being investigated for application into the surgical site to reduce postoperative pain and the need for opioid analgesics for 72 hours.

Masimo is a global medical technology company that develops and produces a wide array of industry-leading monitoring technologies, including innovative measurements, sensors, patient monitors, and connectivity solutions. In 1995, Masimo debuted SET^® Measure-through Motion and Low Perfusion™ pulse oximetry, estimated to be used on more than 100 million patients annually. In 2005, Masimo introduced rainbow^® Pulse CO-Oximetry, allowing noninvasive and continuous monitoring of additional physiologic parameters that previously could only be measured invasively, such as total hemoglobin (SpHb^®). We continue to advance noninvasive monitoring, connectivity, and automation with innovations like the Root^® patient monitoring and connectivity hub and the Patient SafetyNet™ supplemental remote monitoring solution.

Medtronic plc (www.medtronic.com), is among the world’s largest medical technology, services and solutions companies – alleviating pain, restoring health and extending life for millions of people around the world. Medtronic employs more than 86,000 people worldwide, serving physicians, hospitals and patients in more than 150 countries. The company is focused on collaborating with stakeholders around the world to take healthcare Further, Together.

Vertex, a global biotechnology company, invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia and continues to advance its research in these diseases. Vertex has a broad and deep clinical pipeline across a range of modalities for other serious diseases where it has deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency.

To learn more about ASA’s Industry and Corporate Support programs, please visit the Partner With Purpose website.